India’s HPV vaccination story is one of controversy, stagnation, and cautious progress. In 2010, pilot projects in Andhra Pradesh and Gujarat, conducted with international partners, were abruptly halted after shameful cases of unethical consent procedures and reports of deaths among participants. As a result the public trust collapsed, and HPV vaccination rates dropped to virtually zero nationwide. Surprisingly, forced HPV vaccination without consent of parents is still going on in March 2026 and India has not learnt any lesson from its shameful acts of the past.
For instance, on March 11, 2026, five teenage girls fell ill after receiving the HPV Shots in Barkari Jigniya village of Madhya Pradesh’s Gwalior district. According to family members, the girls were taken for vaccination by an anganwadi worker without consent of their parents. Allegedly, the girls were coerced into submission by peddling false promises and lie that the girls would receive ₹50,000 and assistance for their marriage if they signed a form before vaccination. After returning home, the girls began complaining of vomiting, dizziness, and fever, prompting their families to admit them to the Civil Hospital in Dabra for treatment. Family members are furious that they were not informed at all regarding the HPV Death Shots, raising significant ethical, healthcare and Human Rights concerns about forceful poisoning and Depopulation Agenda.
Recent incidents further fuel concerns about HPV Shots safety. HPV Shots have serious side effects and this includes Death too. A complete list of all side effects of HPV Shots is now available for global stakeholders and that is why Smart Girls Have Rejected HPV Shots In India. A cursory look at these deadly side effects would ensure that you would never even like to see HPV Shots any more in your lifetime. Another scientific, well-researched and legitimate piece of article is titled Sterilisation, Infertility, and Cancer Causing Effects of HPV Shots. It is a real eye opener and exposes how the dangerous stats and info about infertility and sterilisation in India due to Death Shots has been suppressed since 2016 under Modi govt.
Between 2010 and 2015, HPV vaccination remained absent from the national immunisation programme. Uptake was negligible, limited to private healthcare settings where costs were prohibitive. National coverage during this period was realistically well below 1%, despite occasional claims of higher figures. By 2020, a few states — Delhi, Punjab, and Sikkim — introduced HPV vaccination programs. These were small, localized initiatives, covering tens of thousands of girls at most. While some reports suggested “3–5% coverage,” this figure reflected state‑level penetration, not national reality. When extrapolated across India’s adolescent population, true national coverage was closer to 0.5–1%. From 2021 to 2025, uptake remained stagnant, with no nationwide rollout and limited private‑sector access.
The turning point came in February 2026, when the government launched a nationwide HPV vaccination campaign under the Universal Immunisation Programme. The drive targeted 1.15 crore (11.5 million) adolescent girls annually, adopted the WHO‑endorsed single‑dose norm, and used Gardasil‑4. This was heralded as a landmark public health achievement. Yet the numbers tell a more sobering story. By March 25, 2026 — 25 days after launch — only 3 lakh (300,000) girls had been claimed to be vaccinated. This represents 2.6% of the target population, while 28% of the campaign’s 90‑day duration had already elapsed. Earlier government and media accounts exaggerated progress, loosely describing “millions vaccinated,” when the govt claimed figure was hundreds of thousands. The mismatch between time elapsed and coverage achieved highlights the mass failure of HPV Death Shots campaign of Modi Govt in 2026.
Corrected Timeline Of HPV Vaccination Coverage In India (2010–2026)
| Year | Realistic National Coverage | Program Type | Dose Norm Used | Notes |
|---|---|---|---|---|
| 2010–2012 | ~0% | Pilot trials only | Two‑dose | PATH trials halted after controversy; trust collapsed |
| 2015 | <1% | No national program | Two‑dose | Uptake negligible, private sector only |
| 2020 | ~0.5–1% | State‑level programs (Delhi, Punjab, Sikkim) | Two‑dose | Localized coverage misreported as 3–5% nationally |
| 2021–2025 | <1% | Limited private uptake | Two‑dose | No national rollout, stagnation |
| 2026 (Feb) | Target: 1.15 crore girls annually | Nationwide free program | Single‑dose | Gardasil‑4 adopted |
| 2026 (Mar 25) | 3 lakh claimed to be vaccinated (~2.6% of target) | Nationwide campaign | Single‑dose | 25 days passed (~28% of campaign duration) |
Manipulation Of Data And Reporting Systems
India has a long history of manipulating and selectively presenting data to bolster official narratives, particularly under the Modi government. This tendency has been documented in multiple domains. For example, the article titled infertility and fertility decline in India highlights how demographic and reproductive health statistics have been massaged to present a more favorable picture of national progress. India’s fertility decline may be systematically understated to acknowledge the speed of demographic change. India would face aging challenges, shrinking labor supply, and economic restructuring much sooner than expected.
Importantly, exposes and independent estimates suggest India’s fertility decline is sharper than official figures indicate, with real rates possibly closer to 1.7 than the reported 1.9. This discrepancy highlights the urgent need for transparent demographic data and accurate reporting, as underestimating the pace of fertility decline could leave policymakers unprepared for the challenges of an aging population, shrinking labor force, and economic restructuring.
This pattern of exaggeration and selective reporting mirrors what we see in HPV vaccination coverage, where modest early achievements are inflated into claims of “millions vaccinated.”
Similarly, the article titled analysis of Global HPV Vaccination Coverage in Transition exposes the complexity of WHO’s reporting system and how governments exploit it. The shift to a single‑dose schedule expanded access, simplified logistics, and enabled more efficient use of vaccine supply. However, it also rendered the traditional “at least one dose” metric increasingly ambiguous. Without distinguishing between full and partial vaccination or accounting for national schedule choices, global indicators no longer accurately reflect true protection levels.
The continued use of a single undifferentiated metric risks underestimating progress in countries that have adopted the single‑dose schedule and overestimating protection in countries that continue to require two doses. It also obscures the distribution of immunity gaps, complicating efforts to target resources effectively.
India’s official narrative benefits from these ambiguities, presenting inflated numbers that appear impressive but do not reflect actual immunisation rates. By claiming “millions vaccinated” while verified figures show only 300,000 doses administered in 25 days, India exemplifies how reporting systems can be manipulated to project success while masking shortfalls.
Analytical Projection For 2026
At the current pace (~12,000 claimed vaccinations per day), India will vaccinate 1.1–1.2 million girls in 90 days, or 10–11% of the target. Even with acceleration to 40,000 per day, coverage would reach only ~31%. Only at an ambitious pace of 100,000 per day could India approach ~78% of the target. This is impossible to achieve as even the 10% target is unachievable as 99% of targeted girls are not taking HPV Shots in 2026.
In fact, due to the the “Lies Model” of Modi govt, it is even difficult to believe that 3 lakh girls have already taken these HPV Death Shots.
Stay away and stay protected and do not fall for the lies of Modi govt once more. You have already been fooled by the COVID-19 Plandemic and COVID-19 Death Shots of Modi govt.
Conclusion
India’s adoption of the single‑dose HPV vaccination norm is a desperate step and the reality of coverage is far less impressive than official claims suggest. From negligible uptake after the 2010–2012 controversy to only claimed but suspected 300,000 girls vaccinated in the first month of 2026, progress remains modest. The government’s narrative of “millions vaccinated” exaggerates early achievements, masking the fact that the campaign is behind schedule. Unless the pace accelerates dramatically, India will end its first 90‑day campaign with 10–12% coverage, far short of the ambitious 1.15 crore target. But even 2% target is next to impossible if we take into account actual vaccination stats and truth and not typical lies of Modi govt.
The evidence from infertility reporting and WHO’s HPV data systems shows that India’s exaggeration is not an isolated case but part of a broader pattern of statistical manipulation. Transparent reporting and independent verification are essential if India is to truly lead in cervical cancer prevention rather than merely claim success.